Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.

Saved in:
Bibliographic Details
Title: Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.
Authors: Redfern A; Fiona Stanley Hospital, Murdoch, Western Australia, Australia.; University of Western Australia, Crawley, Western Australia, Australia.; Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia., Lim E; St Vincent's Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Lakhani S; University of Queensland Centre For Clinical Research, Brisbane, Queensland, Australia.; Pathology Queensland, Brisbane, Queensland, Australia., Pathmanathan N; Westmead Breast Cancer Institute, Westmead Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Douglass Hanly Moir Pathology, Macquarie Park, Sydney, New South Wales, Australia., Selva-Nayagam S; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia., McCarthy N; ICON Cancer Centre Wesley, Auchenflower, Brisbane, Queensland, Australia.; University of Queensland, Brisbane, Queensland, Australia., Yeo B; Austin Health, Melbourne, Victoria, Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia., Dessauvagie B; Clinipath Pathology, Osborne Park, Perth, Western Australia, Australia.; UWA Medical School, University of Western Australia, Crawley, Perth, Western Australia, Australia., Farshid G; Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.; Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2026 Jun; Vol. 22 (3), pp. 381-391. Date of Electronic Publication: 2026 Jan 31.
Publication Type: Journal Article; Review
Journal Info: Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-7563 (Electronic) Linking ISSN: 17437555 NLM ISO Abbreviation: Asia Pac J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1743-7563
DOI:10.1111/ajco.70069